These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 126043)

  • 1. The effect of epsilon-amino caproic acid on the gross conformation of plasminogen and plasmin.
    Violand BN; Sodetz JM; Castellino FJ
    Arch Biochem Biophys; 1975 Sep; 170(1):300-5. PubMed ID: 126043
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasminogen-plasmin system. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor.
    Abiko Y; Iwamoto M; Tomikawa M
    Biochim Biophys Acta; 1969; 185(2):424-31. PubMed ID: 4241289
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury.
    Takeda Y; Parkhill TR; Nakabayashi M
    J Clin Invest; 1972 Oct; 51(10):2678-85. PubMed ID: 4262519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.
    Wallén P; Wiman B
    Biochim Biophys Acta; 1972 Jan; 257(1):122-34. PubMed ID: 4257942
    [No Abstract]   [Full Text] [Related]  

  • 5. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 6. Human plasminogen: a summary of studies on its isolation, characterization and activation mechanism.
    Rickli EE
    Immunochemistry; 1975 Jul; 12(6-7):629-32. PubMed ID: 126948
    [No Abstract]   [Full Text] [Related]  

  • 7. Isoelectric focusing of human plasminogen, plasmin, and derived heavy (A) and light (B) chains.
    Robbins KC; Summaria L
    Ann N Y Acad Sci; 1973 Jun; 209():397-404. PubMed ID: 4268482
    [No Abstract]   [Full Text] [Related]  

  • 8. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
    Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
    Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid.
    Sjöholm I
    Eur J Biochem; 1973 Nov; 39(2):471-9. PubMed ID: 4272770
    [No Abstract]   [Full Text] [Related]  

  • 10. EPSILON-AMINOCAPROIC ACID (EACA).
    NAHUM LH
    Conn Med; 1964 Sep; 28():641-5. PubMed ID: 14201313
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of plasmin binding and urokinase activation of plasminogen bound to the Heymann nephritis autoantigen, gp330.
    Kanalas JJ
    Arch Biochem Biophys; 1992 Dec; 299(2):255-60. PubMed ID: 1280065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the kringle domain in plasminogen activation with staphylokinase.
    Arai K; Madoiwa S; Mimuro J; Asakura S; Matsuda M; Sako T; Sakata Y
    J Biochem; 1998 Jan; 123(1):71-7. PubMed ID: 9504411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TISSUE ACTIVATOR OF PLASMINOGEN.
    LACK CH; ALI SY
    Nature; 1964 Mar; 201():1030-1. PubMed ID: 14191573
    [No Abstract]   [Full Text] [Related]  

  • 14. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.
    Claeys H; Vermylen J
    Biochim Biophys Acta; 1974 Apr; 342(2):351-9. PubMed ID: 4275496
    [No Abstract]   [Full Text] [Related]  

  • 15. On the primary structure of human plasminogen and plasmin. Purification and characterization of cyanogen-bromide fragments.
    Wiman B; Wallén P
    Eur J Biochem; 1975 Sep; 57(2):387-94. PubMed ID: 126158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen-plasmin system. 3. Kinetics of plasminogen activation and inhibition of plasminogen-plasmin system by some synthetic inhibitors.
    Iwamoto M; Abiko Y; Shimizu M
    J Biochem; 1968 Dec; 64(6):759-67. PubMed ID: 4238017
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
    GORDON AM; MCNICOL GP; DUBBER AH; MCDONALD GA; DOUGLAS AS
    Br Med J; 1965 Jun; 1(5451):1632-5. PubMed ID: 14295319
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of guanidine compounds on the activation of human plasminogen by streptokinase and on the rates of hydrolysis of p-toluenesulfonyl-L-arginine methyl ester by plasmin and activator.
    Roberts PS; Burkat RK
    Biochim Biophys Acta; 1966 Jun; 118(3):592-603. PubMed ID: 4226322
    [No Abstract]   [Full Text] [Related]  

  • 20. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen.
    Wiman B; Lijnen HR; Collen D
    Biochim Biophys Acta; 1979 Jul; 579(1):142-54. PubMed ID: 157166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.